英文名稱 Anti-Bcl-10/CLAP/CIPER

中文名稱 Bcl-10抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 信號轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 細(xì)胞周期蛋白 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量 predicted molecular weight: 26kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanBcl-10 C-terminus

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -69 °C for oneyear.

別 名 Bcl10; B cell CLL/lymphoma 10; B celllymphoma/leukemia10; B-cell leukemia/lymphoma 10; Bcl 10; c E10; c-E10; C81403;CARD containing apoptotic signaling protein; CARD containing molecule enhancingNF kappa B; CARD containing molecule enhancing NF kB; CARD containing moleculeenhancing NFkB; CARD containing proapoptotic protein; CARD like apoptoticprotein; CARMEN; Caspase recruiting domain containing protein; cCARMEN; cE 10; cE10;CED 3/ICH 1 prodomain homologous E10 like regulator; CED3/ICH1 prodomainhomologous E10 like regulator; Cellular E10; Cellular homolog of vCARMEN;CIPER; CLAP; hCLAP; Mammalian CARD containing adapter molecule E10; mE 10;mE10; R-RCD1; BCL10_HUMAN.